Search

for
Search:

Sort by

Research

690-720 / 1000+ results

research [A patient with advanced recurrent breast cancer who firmly resisted hair loss and was then treated by combination therapy with high-dose toremifene and capecitabine].

March 2007

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

research Studies on a hair growth stimulant,procyanidin B-2

January 2002

research Assessment of the skin efficacy and acceptability of a cosmetic product in the treatment of the forearm hypertrichosis in female patients

1 citations , December 2020 in “Journal of Cosmetic Dermatology”

The cosmetic product effectively reduced hair growth and thickness on forearms.

research 2‐Deoxy‐d‐glucose enhances tonic inhibition through the neurosteroid‐mediated activation of extrasynaptic GABA_A receptors

44 citations , October 2016 in “Epilepsia”

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

research Valproic acid in childhood epilepsy: anticonvulsive efficacy in relation to its plasma levels.

17 citations , October 1980 in “PubMed”

Valproic acid is effective for controlling seizures in children, especially as a single treatment, with some side effects.

research Pancreatitis associated with valproic acid therapy for epilepsy

73 citations , January 1980 in “Annals of Neurology”

Valproic acid can cause serious side effects, including pancreatitis and even death.

research NEW PROPRIETARY BRANDS: Cefaclor monohydrate

October 2004 in “Australian Prescriber”

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

research Photo-Crosslinked and Photothermal Flammulina Velutipes Polysaccharide Hydrogel Loaded with Caffeic Acid-Copper Nanozyme for Diabetic Wound Healing

January 2024 in “SSRN Electronic Journal”

research Severe and Fatal Phenobarbitone Eruptions

14 citations , June 1952 in “The BMJ”

Phenobarbitone can cause severe and sometimes fatal skin reactions.

research Cemotherapi Induce Alopecia Due Carboplatin-Paclitaxel Regiment

1 citations , September 2024 in “International Journal of Advanced Multidisciplinary Research and Studies”

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

research Reversible severe myopathy during treatment with finasteride

15 citations , April 1997 in “Muscle & Nerve”

research Reversible severe myopathy during treatment with finasteride

5 citations , April 1997 in “Muscle & Nerve”

research Low Serum Biotinidase Activity in Children with Valproic Acid Monotherapy

73 citations , October 2001 in “Epilepsia”

Children taking higher doses of valproic acid had lower biotinidase activity, which may lead to biotin deficiency, but biotin supplements could help.

research Photo-Cross-Linkedand Photothermal Flammulina velutipes Polysaccharide Hydrogel Loadedwith Caffeic Acid-Copper Nanozyme for Diabetic Wound Healing

September 2025 in “OPAL (Open@LaTrobe) (La Trobe University)”

The hydrogel effectively heals diabetic wounds and promotes hair growth.

Photo-Cross-Linked and Photothermal Flammulina Velutipes Polysaccharide Hydrogel Loaded with Caffeic Acid-Copper Nanozyme for Diabetic Wound Healing

research Photo-Cross-Linked and Photothermal Flammulina velutipes Polysaccharide Hydrogel Loaded with Caffeic Acid-Copper Nanozyme for Diabetic Wound Healing

September 2025 in “ACS Applied Materials & Interfaces”

The hydrogel effectively heals diabetic wounds, closing over 90% within 7 days.

research UNITY INOVA NMR Spectrometer Systems Installation Planning

January 2004 in “Headache”

Divalproex sodium significantly improved headaches in two-thirds of patients.

research The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma

21 citations , November 2018 in “Journal of the European Academy of Dermatology and Venereology”

The combination of encorafenib and binimetinib caused few skin issues.

research Advancing mitochondrial therapeutics: Synthesis and pharmacological evaluation of pyrazole-based inhibitors targeting the mitochondrial pyruvate carrier

4 citations , December 2024 in “European Journal of Medicinal Chemistry”

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

research An overview of the role of carboxytherapy in dermatology

4 citations , March 2023 in “Journal of Cosmetic Dermatology”

Carboxytherapy is a safe and effective treatment for improving skin appearance and treating various skin conditions, with mild side effects.

research BindingDB Entry 50021519: Discovery of (2S)-N-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment.

January 2025

research Preparation, solubility, and anti-inflammatory effects of a complex of diphenylcyclopropenone/β-cyclodextrin derivatives as the treatment of alopecia areata

1 citations , August 2024 in “Journal of Pharmacy & Pharmaceutical Sciences”

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

research Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson–Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies

4 citations , May 2023 in “Cells”

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

research Fabricating the multibranch carboxyl-modified cellulose for hemorrhage control

9 citations , December 2023 in “Materials Today Bio”

Multibranch carboxyl-modified cellulose is a safe and effective material for stopping bleeding.

research 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata

September 2024 in “Journal of the American Academy of Dermatology”

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

research Solubilization and Solid‐State Characterization of a Poorly Soluble 5‐α Reductase Inhibitor

January 2004 in “Drug Development and Industrial Pharmacy”

GI197111X is best dissolved in Capmul MCM for trials.

research Targeting Solid Tumours With Potassium Channel Activators. A Return to Fundamentals?

1 citations , November 2014 in “Thérapie”

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

research Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.

90 citations , January 1989 in “PubMed”

← Previous page Next page →

Search

for
Search:

Research

research [A patient with advanced recurrent breast cancer who firmly resisted hair loss and was then treated by combination therapy with high-dose toremifene and capecitabine].

research Studies on a hair growth stimulant,procyanidin B-2

research Assessment of the skin efficacy and acceptability of a cosmetic product in the treatment of the forearm hypertrichosis in female patients

research 2‐Deoxy‐d‐glucose enhances tonic inhibition through the neurosteroid‐mediated activation of extrasynaptic GABA_A receptors

research Valproic acid in childhood epilepsy: anticonvulsive efficacy in relation to its plasma levels.

research Pancreatitis associated with valproic acid therapy for epilepsy

research NEW PROPRIETARY BRANDS: Cefaclor monohydrate

research Photo-Crosslinked and Photothermal Flammulina Velutipes Polysaccharide Hydrogel Loaded with Caffeic Acid-Copper Nanozyme for Diabetic Wound Healing

research Severe and Fatal Phenobarbitone Eruptions

research Cemotherapi Induce Alopecia Due Carboplatin-Paclitaxel Regiment

research Reversible severe myopathy during treatment with finasteride

research Reversible severe myopathy during treatment with finasteride

research Low Serum Biotinidase Activity in Children with Valproic Acid Monotherapy

research Photo-Cross-Linkedand Photothermal Flammulina velutipes Polysaccharide Hydrogel Loadedwith Caffeic Acid-Copper Nanozyme for Diabetic Wound Healing

research Photo-Cross-Linked and Photothermal Flammulina velutipes Polysaccharide Hydrogel Loaded with Caffeic Acid-Copper Nanozyme for Diabetic Wound Healing

research UNITY INOVA NMR Spectrometer Systems Installation Planning

research The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma

research Advancing mitochondrial therapeutics: Synthesis and pharmacological evaluation of pyrazole-based inhibitors targeting the mitochondrial pyruvate carrier

research An overview of the role of carboxytherapy in dermatology

research BindingDB Entry 50021519: Discovery of (2S)-N-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment.

research Preparation, solubility, and anti-inflammatory effects of a complex of diphenylcyclopropenone/β-cyclodextrin derivatives as the treatment of alopecia areata

research Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson–Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies

research Fabricating the multibranch carboxyl-modified cellulose for hemorrhage control

research 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata

research Solubilization and Solid‐State Characterization of a Poorly Soluble 5‐α Reductase Inhibitor

research Targeting Solid Tumours With Potassium Channel Activators. A Return to Fundamentals?

research Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.

research SAT-435 When The Cure Becomes The Cause: Adrenal Insufficiency In Cushing’s Management

research Protein-based functional hydrogel improves cutaneous nerve repair and diabetic wound healing

research Folate-cyclodextrin Conjugate for Targeted Chemotherapy